LGALS3 and metabolic syndrome: Moreover, higher serum and fecal content of Gal-3 was observed in subjects with UC and metabolic syndrome, showing clinically and histologically milder disease compared to subjects suffering from UC only [49], indicating that Gal-3 may also be involved in the mechanism limiting the inflammatory process in UC.